{"article_title": "Critical Reports Mount On Hepatitis C Pill Costs", "article_keywords": ["c", "mount", "reports", "costs", "critical", "pill", "hepatitis"], "article_url": "http://www.forbes.com/sites/brucejapsen/2015/03/17/critical-reports-mount-on-hepatitis-c-pill-costs/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "The staggering costs of hepatitis C pills are the subject of two new medical journal reports pointing out that employers, insurers and the U.S. government will have difficulty paying for these pricey pills for years to come. The new issue of the Annals of Internal Medicine, the journal published by the [...]", "title": "Critical Reports Mount On Hepatitis C Pill Costs", "url": "http://www.forbes.com/sites/brucejapsen/2015/03/17/critical-reports-mount-on-hepatitis-c-pill-costs/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/10/Sovaldi--1940x1298.jpg", "updated_time": "2015-08-04T10:06:09-04:00", "type": "article"}, "twitter": {"description": "The staggering costs of hepatitis C pills are the subject of two new medical journal reports pointing out that employers, insurers and the U.S. government will have difficulty paying for these pricey pills for years to come. The new issue of the Annals of Internal Medicine, the journal published by the [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/10/Sovaldi--1940x1298.jpg", "title": "Critical Reports Mount On Hepatitis C Pill Costs", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2015-08-04", "published": "2015-03-17", "id": "blogAndPostId/blog/post/2125-10369"}, "news_keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "The staggering costs of hepatitis C pills are the subject of two new medical journal reports pointing out that employers, insurers and the U.S. government will have difficulty paying for these pricey pills for years to come. The new issue of the Annals of Internal Medicine, the journal published by the [...]"}, "_id": "\"57477af36914bd0286fc9868\"", "article_summary": ""}